Home » Stocks » NARI

Inari Medical, Inc. (NARI)

Stock Price: $95.86 USD 0.00 (0.00%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $95.00 -0.86 (-0.90%) Jan 15, 7:55 PM
Market Cap 4.88B
Revenue (ttm) 110.95M
Net Income (ttm) 7.16M
Shares Out 48.34M
EPS (ttm) 0.15
PE Ratio 647.49
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $95.86
Previous Close $95.86
Change ($) 0.00
Change (%) 0.00%
Day's Open 94.46
Day's Range 93.57 - 96.80
Day's Volume 642,662
52-Week Range 42.51 - 96.80

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 week ago

IRVINE, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform t...

Seeking Alpha - 2 months ago

Inari Medical continues to live up to expectations, showing very solid growth and strong margins. I like the business a lot, yet have not initiated a position yet.

Seeking Alpha - 2 months ago

US IPO market activity is picking back up ahead of the Thanksgiving holiday, with six IPOs scheduled to raise $3.4 billion in the week ahead. Biotech research product provider Maravai LifeScie...

Other stocks mentioned: FHTX, GHLD, MCFE, MSP, SLQT
The Motley Fool - 2 months ago

There's good reason to think these young stocks have bright futures ahead.

Other stocks mentioned: ISRG
GlobeNewsWire - 2 months ago

IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform ...

Seeking Alpha - 2 months ago

Inari Medical, Inc. (NARI) CEO Bill Hoffman on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 2 months ago

IRVINE, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform ...

GlobeNewsWire - 2 months ago

IRVINE, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform ...

GlobeNewsWire - 2 months ago

IRVINE, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) announced today that its management team will participate at the Canaccord Genuity Virtual MedTec...

GlobeNewsWire - 2 months ago

IRVINE, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced it will release financial results for the third quarter of 2020 after market clos...

The Motley Fool - 2 months ago

These fast-growing medical device companies could outperform the S&P 500 over the next several years.

Other stocks mentioned: DXCM
GlobeNewsWire - 3 months ago

IRVINE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transfo...

GlobeNewsWire - 4 months ago

IRVINE, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transfor...

GlobeNewsWire - 4 months ago

IRVINE, Calif., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform...

Seeking Alpha - 5 months ago

Inari Medical, Inc. (NARI) CEO Bill Hoffman on Q2 2020 Results - Earnings Call Transcript

Investors Business Daily - 5 months ago

Hot IPO stock Inari Medical late Tuesday reported earnings and sales that beat expectations, but in the regular session shares reversed after hitting an all-time high for a third straight day....

GlobeNewsWire - 5 months ago

IRVINE, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transfor...

GlobeNewsWire - 5 months ago

IRVINE, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced the company will be participating in the upcoming Canaccord Genuity 40th Annual...

GlobeNewsWire - 5 months ago

IRVINE, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced it will release financial results for the second quarter of 2020 after market c...

The Motley Fool - 7 months ago

Its medical devices offer promising clinical benefits over the competition.

GlobeNewsWire - 7 months ago

IRVINE, Calif., May 27, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform...

Market Watch - 7 months ago

Shares of Inari Medical Inc. NARI, +114.07% rocketed out of the gate Friday, as they opened for trading at prices that were more than double the initial public offering price.

Market Watch - 7 months ago

Inari Medical Inc. increased that number of shares it was selling in its initial public offering, which priced late Thursday above the expected range.

About NARI

Inari Medical, a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It produces ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.

Industry
Medical Devices
IPO Date
May 22, 2020
CEO
William H. Hoffman
Employees
199
Stock Exchange
NASDAQ
Ticker Symbol
NARI
Full Company Profile

Financial Performance

In 2019, Inari Medical's revenue was $51.13 million, an increase of 648.73% compared to the previous year's $6.83 million. Losses were -$1.19 million, -88.26% less than in 2018.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for Inari Medical stock is "Buy." The 12-month stock price forecast is 91.00, which is a decrease of -5.07% from the latest price.

Price Target
$91.00
(-5.07% downside)
Analyst Consensus: Buy